Finally, B-lymphoid tyrosine kinase (BLK) expression in nodal PTCL should be evaluated, as it is commonly found in CTCL, and dasatinib showed some degree of effectiveness in such instances (73). The gene discussed is BLK; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.